<p>SHL Telemedicine Ltd. held a Special General Meeting on September 16, 2025, in Tel Aviv, Israel. During the meeting, the shareholders approved the repricing of options granted to CEO David Arnon. Additionally, the shareholders approved the grant of 100,000 options to the Chairman of the Board of Directors, Itamar Offer. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SHL Telemedicine Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-25-003338), on September 16, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

SHLT

<p>SHL Telemedicine Ltd. held a Special General Meeting on September 16, 2025, in Tel Aviv, where shareholders approved the repricing of options for CEO David Arnon and granted 100,000 options to Chairman Itamar Offer. This information is based on content published via EDGAR by SHL Telemedicine Ltd.</p>

SHL Telemedicine Ltd. Held Special General Meeting of Shareholders